A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02110069
Recruitment Status : Recruiting
First Posted : April 10, 2014
Last Update Posted : November 8, 2018
Information provided by (Responsible Party):
Denise Martin Adams, Boston Children’s Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2022
  Estimated Study Completion Date : December 2026